Author | Year | Type | No. of patients | MVr (n) | MVR (n) | Place of Study | Outcome accessed |
---|---|---|---|---|---|---|---|
Nishida et al. [7] | 2018 | Retrospective cohort | 86 | 23 | 63 | Sakakibara Heart Institute | Operative mortality, postoperative morbidities, Long-term survival (mean follow-up period of 76.3 ± 55.0 months) |
Zegdi (Late) et al. [9] | 2008 | Retrospective cohort | 13 | 9 | 4 | Service de Chirurgie Cardiovasculaire, Paris, France | Mechanisms of late failure, Long-term results were assessed on the basis of NYHA functional class, electrocardiogram and echocardiography |
Zegdi et al. [11] | 2008 | Retrospective cohort | 43 | 21 | 22 | Service de Chirurgie Cardiovasculaire, Paris, France | Feasibility of Redo Mitral Valve Repair, Mechanisms of late Failure, Operative Mortality and Morbidity and Long-Term Outcomes. |
Kwedar et al. [12] | 2017 | Retrospective cohort | 812 | 130 | 682 | US (Medicare Database) | Characteristics of Reoperation Cohort, Outcomes of Reoperation, Time to Reoperation, Hospital Mortality According to Hospital Annual Mitral Procedure Volume and Long-Term Survival |
Ma et al. [13] | 2018 | Retrospective cohort | 40 | 23 | 17 | Shanghai Chest Hospital | Early mortality, Early major morbidities, Survival, reoperation for recurrent mitral valve pathology and echocardiographic data |
Kilic et al. [14] | 2018 | Retrospective cohort | 305 | 48 | 257 | University of Pennsylvania Health System | The primary outcome was operative mortality. Secondary outcome included postoperative complications and long term freedom from death. |
Suri et al. [15] | 2006 | Retrospective cohort | 145 | 64 | 81 | Mayo Clinic Rochester | Indications for Reoperation, Predictors of Late Mortality, Predictors of Third Mitral Operation and Follow up data |
Dumont et al. [16] | 2007 | Retrospective cohort | 188 | 68 | 120 | The Cleveland Clinic | Mechanisms and Timing of Repair Failure, Freedom from reoperation, Incremental Risk Factors for Death after Mitral Valve Reoperation |